BSE filing, NSE: GKSL. Summary written from the filing by ALFA Finder's alert engine.
Gujarat Kidney and Super Speciality Ltd: key numbers
- Share price
- ₹171.87
- Market cap
- ₹1,355 Cr
- Revenue (annual)
- ₹82.01 Cr
- Net profit (annual)
- ₹15.50 Cr
- P/E (TTM)
- 85.6×Sector 52.3×
- Promoter holding
- 71.45%+0.00% QoQ
- FII holding
- 6.52%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gujarat Kidney and Super Speciality Ltd
All →Gujarat Kidney and Super Speciality Other Announcement
This is a routine quarterly shareholding pattern disclosure for the period ended September 30, 2026, filed under SEBI Regulation 31.
Gujarat Kidney and Super Speciality Annual General Meeting
Gujarat Kidney and Super Speciality Limited held its 7th Annual General Meeting on September 28, 2026. Shareholders approved financial statements, director appointments, and various regulatory borrowing and investment limits.
Gujarat Kidney and Super Speciality Annual Report
Gujarat Kidney and Super Speciality Limited issued a corrigendum to its FY 2025-26 Annual Report. The update includes missing Secretarial Audit observations and management responses.
Gujarat Kidney and Super Speciality Annual General Meeting
Gujarat Kidney and Super Speciality Limited has issued a notice for its 7th Annual General Meeting scheduled for September 28, 2026. The meeting will address financial statements, director appointments, and related party transactions.
- Value
- ₹1.78 Cr
Gujarat Kidney and Super Speciality Annual General Meeting
Gujarat Kidney and Super Speciality Limited filed a revised Annual Report for FY 2025-26. The document also includes the notice for its 7th Annual General Meeting.
Gujarat Kidney and Super Speciality Annual Report
Gujarat Kidney & Superspeciality Limited released its Annual Report for FY 2025-26. The report includes the notice for the 7th AGM scheduled for September 28, 2026.
Other board meeting date announcements
All →Pix Transmissions Board Meeting Date
Pix Transmissions scheduled its Board Meeting on 6 Nov 2026 to approve Q3 and H1 FY27 unaudited results. No financial figures or monetary values are disclosed in this advance intimation.
Bervin Investment & Leasing Board Meeting Date
Bervin Investment & Leasing scheduled its Board meeting for 4 Nov 2026 to approve un-audited standalone results for Q2 and H1 FY27. The trading window is closed from 1 Oct 2026.
VL e-Governance & IT Solutions Board Meeting Date
VL E-Governance & IT Solutions has scheduled a Board Meeting for 4 November 2026 to consider unaudited standalone results for Q1/H1 FY27. No decisions or figures are reported yet.
Lancer Container Lines Board Meeting Date
Lancer Container Lines will hold its Board meeting on November 6, 2026, to approve Q2 and H1 FY27 results. No decision has been taken yet.
Mukta Arts Board Meeting Date
Mukta Arts will hold a board meeting on 5 November 2026 to consider unaudited half-year results. The trading window stays closed until the results are declared.
Sangam Finserv Board Meeting Date
Sangam Finserv scheduled a board meeting for 4 November 2026 to approve Q2 FY27 unaudited results. Trading window stays closed until 48 hours post-declaration.